Cargando…
Prognostic Value of Choline and Other Metabolites Measured Using (1)H-Magnetic Resonance Spectroscopy in Gliomas: A Meta-Analysis and Systemic Review
Glioma is the most prevalent primary central nervous system malignant tumor, with high heterogeneity observed among different grades; therefore, non-invasive prediction of prognosis could improve the clinical management of patients with glioma. (1)H-magnetic resonance spectroscopy (MRS) can estimate...
Autores principales: | Shi, Yixin, Liu, Delin, Kong, Ziren, Liu, Qianshu, Xing, Hao, Wang, Yuekun, Wang, Yu, Ma, Wenbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788620/ https://www.ncbi.nlm.nih.gov/pubmed/36557257 http://dx.doi.org/10.3390/metabo12121219 |
Ejemplares similares
-
(18)F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma
por: Kong, Ziren, et al.
Publicado: (2019) -
An online survival predictor in glioma patients using machine learning based on WHO CNS5 data
por: Ye, Liguo, et al.
Publicado: (2023) -
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors
por: Chen, Wenlin, et al.
Publicado: (2023) -
Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023) -
Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress
por: Wang, Yaning, et al.
Publicado: (2021)